ask="0.950"
ask_size="100"
average_daily_volume="1403560"
bid="0.900"
bid_size="600"
book_value="0.606"
change="-0.005"
change_from_200_day_moving_average="-1.783"
change_from_50_day_moving_average="-0.039"
change_from_52_week_high="-4.025"
change_From_52_week_low="0.405"
change_in_percent="-0.549%"
close="0.905"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.237"
ebitda="-8.78M"
eps_estimate_current_year="-1.120"
eps_estimate_next_quarter="-0.250"
eps_estimate_next_year="0.190"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.960"
high_52_weeks="4.930"
last_trade_date="1/20/2017"
last_trade_price="0.905"
last_trade_size="300"
last_trade_time="4:00pm"
low="0.901"
low_52_weeks="0.500"
market_capitalization="6.46M"
moving_average_200_day="2.688"
moving_average_50_day="0.944"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.330"
open="0.901"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-66.337%"
percent_change_from_50_day_moving_average="-4.125%"
percent_change_from_52_week_high="-81.643%"
percent_change_from_52_week_low="+81.000%"
previous_close="0.910"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="4.763"
price_per_book="1.502"
price_per_sales="2.542"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.580"
stock_exchange="NCM"
symbol="OPXA"
volume="219376"
weeks_range_52="0.500 - 4.930"
